07/04/2025
JAMA Network์ ํธ์ง์ง์ ์ค๋ ์์ธ๋ํ๊ต๋ฅผ ๋ฐฉ๋ฌธํด ๊ต์์ง๊ณผ ํ์๋ค์ ๋์์ผ๋ก ๋ฐํ๋ฅผ ์งํํ์ต๋๋ค. ์ด์ด์ ์ผ์ฑ์์ธ๋ณ์์์๋ ์ฐ๊ตฌ์๋ค๊ณผ ๋ง๋ ๋ป๊น์ ๊ต๋ฅ์ ์๊ฐ์ ๊ฐ์ก์ต๋๋ค.
JAMA Editor in Chief ์ด์ ์ปค์คํด ๋น๋น์ค-๋๋ฐ๊ณ (Kirsten Bibbins-Domingo) ๋ฐ์ฌ, JAMA Oncology Editor in Chief ์ด์ ๋
ธ๋ผ ๋์์ค(Nora Disis) ๋ฐ์ฌ, ๊ทธ๋ฆฌ๊ณ JAMA ๋ถํธ์ง์ฅ์ด์ ์กด ์ด๋๋๋ฏธ(John Inadomi) ๋ฐ์ฌ์ ์ด๋ฒ ํ๊ตญ ๋ฐฉ๋ฌธ์ ์ฆ๊ฒ๊ณ ๋ป๊น๊ฒ ์๊ฐํฉ๋๋ค. JAMA์ JAMA Network์ ์์ผ๋ก ํ๊ตญ ์๋ฃ ์ฐ๊ตฌ์ง๋ค๊ณผ์ ํ๋ฐํ ํ๋ ฅ์ ๊ธฐ๋ํ๊ณ ์์ต๋๋ค.
The JAMA Network trip to South Korea continued with visits to Seoul National University for a presentation to faculty and students, and ์ผ์ฑ์์ธ๋ณ์(Samsung Medical Center) for meetings with researchers.
Today the team will return to Seoul National University for a final round of meetings before departing Seoul.
JAMA Network Editor-in-Chief Kirsten Bibbins-Domingo, MD, PhD, JAMA Associate Editor John Inadomi, MD, and JAMA Oncology Editor-in-Chief Nora Disis, MD, greatly enjoyed this trip and look forward to partnering with Korean medical researchers.